Thursday Dec 10 | CiteULike
Mycophenolate mofetil is as efficacious as, but safer than,...
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression Export Rheumatology In Rheumatology, Vol.
Long-term Outcomes of Keratolimbal Allograft for Total Limbal Stem...
Long-term Outcomes of Keratolimbal Allograft for Total Limbal Stem Cell Deficiency Using Combined Immunosuppressive Agents and Correction of Ocular Surface Deficits Lingyi Liang, MD, PhD ; Hosam Sheha, MD, PhD ; Scheffer C. G. Tseng, MD, PhD Arch Ophthalmol.
New cardiology research presented at CHEST 2009
Coronary Risk Factors Increase After Liver Transplantation Patients who have undergone a liver transplant may have a significantly increased risk for developing cardiovascular risk factors.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as ...
Correspondence: Jai Radhakrishnan, Columbia University Medical Center, 622 W. 168th St., PH4124, New York, New York 10032, USA.
Drug May Be Effective for Optical Autoimmune Disease
Mycophenolate mofetil may be a safe and effective treatment for neuromyelitis optica spectrum disorders, according to a study in the September issue of the Archives of Neurology .
Original Contribution: Treatment of Neuromyelitis Optica With...
Background Neuromyelitis optica is the first inflammatory autoimmune demyelinating disease of the central nervous system for which a specific antigenic target has been identified; the marker autoantibody NMO-IgG specifically recognizes the astrocytic water channel aquaporin 4. Current evidence strongly suggests that NMO-IgG may be pathogenic.
Myfortic may cause anemia, FDA and Novartis say
ROCKVILLE,A Md. Patients taking a drug for organ transplants have reported experiencing a type of anemia, the Food and Drug Administration and the druga s manufacturer have announced.
Novartis Warns About Mycophenolate-Mofetil-Related Aplasia
In a carefully worded letter circulated today by FDA, Novartis Pharmaceuticals Corporation warned health care professionals that pure red cell aplasia has occurred in patients treated with a drug that is converted to the active ingredient in Myfortic.
OBSERVATION: Sarcoidal Anemia and Leukopenia Treated With Methotrexate and Mycophenolate Mofetil
Sarcoidal Anemia and Leukopenia Treated With Methotrexate and Mycophenolate Mofetil Andrew H. Kalajian, MD ; Jonathan R. Van Meter, MS ; Jeffrey P. Callen, MD Arch Dermatol.
Health Tip: Managing Menstrual Cramps
Menstrual cramps signal an unwelcome time of the month for many women. The U.S. National Library of Medicine offers these suggestions to help relieve the pain and discomfort of monthly menstrual cramps: Use an over-the-counter pain reliever, such as naproxen sodium or ibuprofen.
Health Tip: Help Improve Your Dental Health
Regular brushing, flossing and checkups are important for good dental health, but there's more you can do to keep your teeth and gums healthy.
Health Tip: Back to School, Back to Sleep
The end of summer signals back to school. And preparing for the school-year routine means getting into a back-to-school sleep schedule.
Cellcept Warning Label Updated
A warning of a risk of pure red cell aplasia has been added to the label and prescribing information for mycophenolate mofetil .
FDA MedWatch - CellCept (mycophenolate mofetil) - cases of Pure Red...
FDA and Roche notified healthcare professionals that cases of Pure Red Cell Aplasia have been reported in patients treated with CellCept.
CellCept Labeling Warns of Rare Blood Disorder
Cases of pure red cell aplasia have been reported in patients treated with the transplant drug mycophenolate mofetil, FDA and Roche Laboratories warned today.
At Long Last, A Win Against Lupus: HGSI Succeeds in Phase III
Lupus is like the Black Knight in Monty Python and the Holy Grail: it's been telling drug developers for decades that "none shall pass" - and when they insist on trying to cross that Phase III bridge, well, then they must die.
OBSERVATION: Mycophenolate Mofetil as Therapy for Pyoderma Gangrenosum
You are seeing this message because your Web browser does not support basic Web standards.
Immunosuppressant Drugs: Required Labeling Changes
Sirolimus , Cyclosporine , Cyclosporine modified , Mycophenolate mofetil , Mycophenolic acid The FDA is requiring the makers of certain immunosuppressant drugs to update their labeling to reflect that immunosuppressed patients are at increased risk for opportunistic infections, such as activation of latent viral infections, including BK ...
FDA Orders Labeling Change For Some Drugs
The U.S. Food and Drug Administration is ordering manufacturers of some immunosuppressant drugs used in kidney transplants to change their labeling.
The question: In people with lupus, the immune system goes awry and turns on the body.
Also on Topix